AGTR1 and metabolic syndrome: In conclusion, our results in rat models show that MetS may generate circulating EVMetS that may increase the progression of neuroinflammation and dopaminergic neurodegeneration through RAS dysregulation in recipient cells, and that this process can be inhibited by treatment with AT1 receptor blockers.